Revenue GrowthDouble-digit top-line growth (~21.8% YoY) indicates sustained demand and market traction. Over the next several months this supports scale economies, revenue diversification and provides runway to invest in operations and marketing, aiding structural recovery if margins improve.

Healthy Gross MarginsHealthy gross profit margins provide a durable buffer against input-cost swings and underpin gross cash generation. If SG&A is controlled, these margins can translate into sustainable operating profits over the medium term, supporting reinvestment and resilience to cyclical pressures.

Stable Equity RatioA stable equity ratio signals a meaningful shareholder-funded capital base, enhancing solvency and lending capacity. Structurally, this reduces short-term refinancing pressure and gives management flexibility to fund strategic initiatives or absorb shocks without immediate dilution.

Bears Say

Net Loss In 2024Recording a net loss erodes retained earnings and returns on equity, showing revenue growth hasn't yet translated into profitability. Persisting losses over months constrain internal funding for capex and R&D and increase reliance on external capital, limiting strategic options.

Rising LeverageAn increased debt-to-equity ratio reflects higher financial leverage and interest burdens. Structurally, greater leverage reduces financial flexibility, raises refinancing risk and amplifies downside during earnings weakness, especially problematic if cash generation remains impaired.

Negative Operating Cash FlowNegative operating cash flow and declining free cash flow indicate weak cash conversion of sales. Over the medium term, persistent cash deficits force dependence on new financing, constrain working capital and capex, and create a structural liquidity risk for ongoing operations.

4935 FAQ

What was Liberta Co., Ltd.’s price range in the past 12 months?

Liberta Co., Ltd. lowest stock price was ¥194.80 and its highest was ¥844.00 in the past 12 months.

What is Liberta Co., Ltd.’s market cap?

Liberta Co., Ltd.’s market cap is ¥8.90B.

When is Liberta Co., Ltd.’s upcoming earnings report date?

Liberta Co., Ltd.’s upcoming earnings report date is May 20, 2026 which is in 92 days.

How were Liberta Co., Ltd.’s earnings last quarter?

Liberta Co., Ltd. released its earnings results on Feb 13, 2026. The company reported ¥7.876 earnings per share for the quarter, beating the consensus estimate of N/A by ¥7.876.

Is Liberta Co., Ltd. overvalued?

According to Wall Street analysts Liberta Co., Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Liberta Co., Ltd. pay dividends?

Liberta Co., Ltd. pays a Annually dividend of ¥10 which represents an annual dividend yield of 0.48%. See more information on Liberta Co., Ltd. dividends here

What is Liberta Co., Ltd.’s EPS estimate?

Liberta Co., Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Liberta Co., Ltd. have?

Liberta Co., Ltd. has 30,262,600 shares outstanding.

What happened to Liberta Co., Ltd.’s price movement after its last earnings report?

Liberta Co., Ltd. reported an EPS of ¥7.876 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -5.161%.

Which hedge fund is a major shareholder of Liberta Co., Ltd.?

Currently, no hedge funds are holding shares in JP:4935

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Liberta Co., Ltd.

Liberta Co., Ltd. (4935) is a Japanese company primarily engaged in the development, manufacturing, and sale of healthcare products, focusing on innovative solutions for skin health and personal care. The company operates in the pharmaceutical and cosmetic sectors, providing a range of products that include topical treatments, skincare formulations, and health supplements. Liberta is committed to leveraging advanced research and technology to enhance consumer well-being and promote healthier skin.